Komtur Pharmaceuticals Headquarters
Am Flughafen 6
DE 79108 Freiburg im Breisgau
Telephone: +49(0)761 504 23 0
Fax: +49(0)761 504 23 15
E-Mail: info@komtur.com

Komtur Pharmaceuticals is a specialized pharmaceutical wholesaler who has been acting successfully on the international pharmaceutical market for over fifty years. We supply patients around the world with urgently needed drugs and carry out complex projects on behalf of pharmaceutical companies.

Our international team of pharmacists, qualified pharmaceutical personnel, and experienced logisticians as well as service employees is intimately familiar with the options, challenges, and regulatory requirements of the national and global pharmaceuticals trade.

Our name stands for custom-tailored solutions for supplying international drugs, sourcing and distributing trial medication, or market launching your innovative drug.

We never forget that every shipment is destined for a patient with individual needs.

From its origins as the Komtur Pharmacy in Freiburg, our company has grown to representation in six countries on three continents with over 65 employees. All subsidiaries of the Komtur Group are in constant contact with one another and work in close consultation with the company headquarters in Freiburg (Breisgau), Germany. Although our roots are in Freiburg, we are represented in core markets of our industry with our subsidiaries. This keeps us continuously updated about innovations of all kinds, new drug developments, or better transport routes.

With the exception of Shanghai, all of our subsidiaries are fully licensed pharmaceutical wholesalers.

The Komtur portfolio includes:

Our customers and partners in Germany and abroad know and appreciate Komtur Pharmaceuticals as a reliable and innovative specialized pharmaceutical wholesaler. Our aim is to keep earning your appreciation.

Go to article: Home | Taming the pharma beastGo to article: In this issueGo to article: Emirates SkyCargoGo to article: ContentsGo to article: TSS Company InsightGo to article: NewsGo to article: Daiichi JitsugyoGo to article: ICCI Company InsightGo to article: ICCIGo to article: The pharma industry briefingGo to article: Novo NordiskGo to article: Swiss WorldCargoGo to article: Understanding drug-resistant TBGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Through time: the breakthroughs that changed the course of HIV treatmentGo to article: Senn ChemicalsGo to article: Qatar AirwaysGo to article: Trouble at Teva: US price-fixing lawsuit adds to generic giant’s woesGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: The dangers of unlicensed stem cell clinicsGo to article: Komtur PharmaceuticalsGo to article: How do cancer cells communicate and can it help us catch them?Go to article: Verona’s ensifentrine: a potentially revolutionary treatment for COPDGo to article: Taming the pharma monster with Hedley ReesGo to article: Capsugel Company InsightGo to article: Altheria SolutionsGo to article: ‘Pay As You Go’ AI for drug discoveryGo to article: AtoZ-CRO GmbHGo to article: PharmaHempGo to article: Event: CPhl KoreaGo to article: EventsGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Next issueGo to article: Hapa Company InsightGo to article: Pfanstiehl